Journal
ENDOCRINOLOGY
Volume 146, Issue 5, Pages 2157-2164Publisher
ENDOCRINE SOC
DOI: 10.1210/en.2004-1572
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL-68743] Funding Source: Medline
- NIAID NIH HHS [AI-15614] Funding Source: Medline
- NIDDK NIH HHS [DK-061483, DK-041096-15] Funding Source: Medline
Ask authors/readers for more resources
Concanavalin A-induced hepatotoxicity was compared in lipodystrophic aP2- nSREBP-1c transgenic mice (LD mice) lacking adipose tissue, obese leptin-deficient ob/ob mice, and lean wild-type (WT) mice. Serum leptin and adiponectin were low in LD mice, whereas ob/ob mice had undetectable leptin, but high adiponectin. Protection from hepatotoxicity was observed in ob/ob, but not in LD mice, despite low cytokine levels and reduced T cell activation and hepatic natural killer T cells in both groups. Administration of adiponectin protected LD mice from hepatotoxicity without altering cytokine levels. In contrast, administration of leptin heightened disease susceptibility by restoring cytokine production. Neutralization of TNF alpha protected LD mice from liver damage. Increased in vivo susceptibility to the hepatotoxic effect of TNF alpha was observed in LD mice. In vitro, adiponectin protected primary hepatocytes from TNF alpha-induced death, whereas leptin had no protective effect. In conclusion, although leptin increases susceptibility to hepatotoxicity by regulating cytokine production and T cell activation, adiponectin protects hepatocytes from TNF alpha-induced death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available